Literature DB >> 18446467

Use of drifts and PLS for the determination of polymorphs of piroxicam alone and in combination with pharmaceutical excipients: a technical note.

Vimon Tantishaiyakul1, Pattakarn Permkam, Krit Suknuntha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18446467      PMCID： PMC2976879          DOI： 10.1208/s12249-007-9003-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN： 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  10 in total

1.  Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD.

Authors:  S Agatonovic-Kustrin; T Rades; V Wu; D Saville; I G Tucker
Journal:  J Pharm Biomed Anal       Date:  2001-07       Impact factor: 3.935

2.  Effect of compressional forces on piroxicam polymorphs.

Authors:  G A Ghan; J K Lalla
Journal:  J Pharm Pharmacol       Date:  1992-08       Impact factor: 3.765

Review 3.  Phase transformation considerations during process development and manufacture of solid oral dosage forms.

Authors:  Geoff G Z Zhang; Devalina Law; Eric A Schmitt; Yihong Qiu
Journal:  Adv Drug Deliv Rev       Date:  2004-02-23       Impact factor: 15.470

4.  Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotection.

Authors:  S Sharma; S Rastogi; V Gupta; D Rohtagi; P Gulati
Journal:  Am J Ther       Date:  1999-07       Impact factor: 2.688

5.  An accurate quantitative analysis of polymorphs based on artificial neural networks.

Authors:  Takehiro Okumura; Masayuki Nakazono; Makoto Otsuka; Kozo Takayama
Journal:  Colloids Surf B Biointerfaces       Date:  2006-04-18       Impact factor: 5.268

6.  Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol.

Authors:  N Kaneniwa; M Otsuka; T Hayashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-08       Impact factor: 1.645

7.  Evaluation of solid-state forms present in tablets by Raman spectroscopy.

Authors:  L S Taylor; F W Langkilde
Journal:  J Pharm Sci       Date:  2000-10       Impact factor: 3.534

8.  Dehydration kinetics of piroxicam monohydrate and relationship to lattice energy and structure.

Authors:  Agam R Sheth; Deliang Zhou; Francis X Muller; David J W Grant
Journal:  J Pharm Sci       Date:  2004-12       Impact factor: 3.534

9.  Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysis.

Authors:  Destari Pratiwi; J Paul Fawcett; Keith C Gordon; Thomas Rades
Journal:  Eur J Pharm Biopharm       Date:  2002-11       Impact factor: 5.571

10.  Characterization of piroxicam crystal modifications.

Authors:  F Vrecer; M Vrbinc; A Meden
Journal:  Int J Pharm       Date:  2003-04-30       Impact factor: 5.875
  10 in total
  3 in total

1.  Characterization of cimetidine-piroxicam coprecipitate interaction using experimental studies and molecular dynamic simulations.

Authors:  Vimon Tantishaiyakul; Krit Suknuntha; Visit Vao-Soongnern
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

2.  Crystal structure transformations and dissolution studies of cimetidine-piroxicam coprecipitates and physical mixtures.

Authors:  Vimon Tantishaiyakul; Sarunyoo Songkro; Krit Suknuntha; Pattakarn Permkum; Pattawee Pipatwarakul
Journal:  AAPS PharmSciTech       Date:  2009-06-12       Impact factor: 3.246

3.  Electrospun Gelatin Nanocontainers for Enhanced Biopharmaceutical Performance of Piroxicam: In Vivo and In Vitro Investigations.

Authors:  Lin Zhao; Omer Mustapha; Shumaila Shafique; Talha Jamshaid; Fakhar Ud Din; Yasir Mehmood; Khaleeq Anwer; Qurrat Ul Ain Yousafi; Talib Hussain; Ikram Ullah Khan; Muhammad Usman Ghori; Yasser Shahzad; Abid Mehmood Yousaf
Journal:  Int J Nanomedicine       Date:  2020-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.